Preview Mode Links will not work in preview mode

COVID-19 Evidence presented by InpharmD™

Mar 5, 2021

A randomized, multi-center, open-label, open-label, factorial clinical trial conducted to examine whether high-dose zinc and/or high-dose ascorbic acid reduce the severity or duration of symptoms compared with usual care among ambulatory patients with SARS-CoV-2 infection.